Moving cannabis from Schedule I to Schedule III changes federal tax rules for licensed businesses, research access, and some federal penalties. It does not legalize cannabis, does not end federal prohibition, and does not change state law.
What the change is
The Controlled Substances Act places drugs in five schedules. Schedule I covers drugs with no accepted medical use and high abuse potential. Schedule III covers drugs with moderate to low physical dependence risk and low psychological dependence risk. Congress placed cannabis in Schedule I in 1970. The Department of Health and Human Services recommended a move to Schedule III in August 2023. The Drug Enforcement Administration published a proposed rule on May 16, 2024. The rule is not final. DEA administrative law judge hearings on the proposal began in 2025.
cannabis rescheduling update news
What rescheduling changes
Federal taxes
Section 280E of the Internal Revenue Code blocks deductions and credits for businesses that traffic in Schedule I or Schedule II substances. That rule applies to state-legal cannabis companies. Schedule III removes 280E. Companies can then deduct payroll, rent, and other ordinary business costs on federal returns.
Research
Schedule I registration adds layers for researchers. Schedule III lowers some barriers and allows more labs to register with the DEA. It does not remove all limits. Researchers still need DEA registration, state licenses, and supply from approved sources.
Federal penalties
Schedule III carries lower statutory maximums than Schedule I for some offenses. Possession without a prescription stays illegal under federal law. Rescheduling does not release anyone now in prison and does not clear criminal records.
Medical use
Schedule III status does not make cannabis a prescription drug. FDA approval is a separate process. The FDA has approved cannabis-derived drugs such as Epidiolex and synthetic THC products such as Marinol and Syndros.
What rescheduling does not do
- It does not legalize adult-use cannabis under federal law.
- It does not change state licensing, testing, or sales rules.
- It does not open interstate commerce in cannabis.
- It does not change banking law. FinCEN guidance and federal banking bills are a separate track.
- It does not remove immigration consequences tied to drug offenses.
- It does not change state tax rates or local zoning.
Where the process stands
The DEA proposal is pending. A final rule needs the DEA Administrator's signature, and courts can review it. Until a final rule takes effect, cannabis remains Schedule I. Tax positions taken under 280E stay in place, and 280E audits continue.
What it means for dispensary customers
For customers at licensed shops, rescheduling changes little at the counter. State law sets age limits, purchase limits, potency caps, and product testing. Federal legalization of adult use would require an act of Congress.